<!doctype html><html lang=en><head><meta charset=utf-8><meta name=description content="coronary angiography PCI Precath checklist  Peripheral arterial exam (radial, femoral, DP, PT pulses; bruits); palmar arch eval (eg, w/ pulse oximetry & plethysmography) not routinely done."><title>coronary angiography PCI</title><meta name=viewport content="width=device-width,initial-scale=1"><link rel="shortcut icon" type=image/png href=https://htlin222.github.io/garden//icon.png><link href=https://htlin222.github.io/garden/styles.547fb332ce56cdc523146ba5ede80d7f.min.css rel=stylesheet><link href=https://htlin222.github.io/garden/styles/_light_syntax.86a48a52faebeaaf42158b72922b1c90.min.css rel=stylesheet id=theme-link><script src=https://htlin222.github.io/garden/js/darkmode.f852e6b434606ed577a6f145a9173070.min.js></script>
<script src=https://htlin222.github.io/garden/js/util.6f22941e242efae60fd84e7c32e874fa.min.js></script>
<link rel=preload href=https://cdn.jsdelivr.net/npm/katex@0.15.1/dist/katex.min.css as=style onload='this.onload=null,this.rel="stylesheet"' integrity=sha384-R4558gYOUz8mP9YWpZJjofhk+zx0AS11p36HnD2ZKj/6JR5z27gSSULCNHIRReVs crossorigin=anonymous><script defer src=https://cdn.jsdelivr.net/npm/katex@0.15.1/dist/katex.min.js integrity=sha384-z1fJDqw8ZApjGO3/unPWUPsIymfsJmyrDVWC8Tv/a1HeOtGmkwNd/7xUS0Xcnvsx crossorigin=anonymous></script>
<script defer src=https://cdn.jsdelivr.net/npm/katex@0.15.1/dist/contrib/auto-render.min.js integrity=sha384-+XBljXPPiv+OzfbB3cVmLHf4hdUFHlWNZN5spNQ7rmHTXpd7WvJum6fIACpNNfIR crossorigin=anonymous></script>
<script defer src=https://cdn.jsdelivr.net/npm/katex@0.16.2/dist/contrib/copy-tex.min.js integrity=sha384-ww/583aHhxWkz5DEVn6OKtNiIaLi2iBRNZXfJRiY1Ai7tnJ9UXpEsyvOITVpTl4A crossorigin=anonymous></script>
<script async src=https://unpkg.com/@floating-ui/core@0.7.3></script>
<script async src=https://unpkg.com/@floating-ui/dom@0.5.4></script>
<script async src=https://htlin222.github.io/garden/js/popover.f03552ccb84d99ca615d1cfb9abde59e.min.js></script>
<script defer src=https://htlin222.github.io/garden/js/code-title.ce4a43f09239a9efb48fee342e8ef2df.min.js></script>
<script defer src=https://htlin222.github.io/garden/js/clipboard.2913da76d3cb21c5deaa4bae7da38c9f.min.js></script>
<script defer src=https://htlin222.github.io/garden/js/callouts.7723cac461d613d118ee8bb8216b9838.min.js></script>
<script>const SEARCH_ENABLED=!1,LATEX_ENABLED=!0,PRODUCTION=!0,BASE_URL="https://htlin222.github.io/garden/",fetchData=Promise.all([fetch("https://htlin222.github.io/garden/indices/linkIndex.9ad492afbbde362996195581891a5972.min.json").then(e=>e.json()).then(e=>({index:e.index,links:e.links})),fetch("https://htlin222.github.io/garden/indices/contentIndex.2685e58463e8d3241d394436ebe1c57e.min.json").then(e=>e.json())]).then(([{index:e,links:t},n])=>({index:e,links:t,content:n})),render=()=>{const e=new URL(BASE_URL),t=e.pathname,n=window.location.pathname,s=t==n;addCopyButtons(),addTitleToCodeBlocks(),addCollapsibleCallouts(),initPopover("https://htlin222.github.io/garden",!0);const o=document.getElementById("footer");if(o){const e=document.getElementById("graph-container");if(!e)return requestAnimationFrame(render);e.textContent="";const t=s&&!1;drawGraph("https://htlin222.github.io/garden",t,[{"/moc":"#4388cc"}],t?{centerForce:1,depth:-1,enableDrag:!0,enableLegend:!1,enableZoom:!0,fontSize:.5,linkDistance:1,opacityScale:3,repelForce:1,scale:1.4}:{centerForce:1,depth:1,enableDrag:!0,enableLegend:!1,enableZoom:!0,fontSize:.6,linkDistance:1,opacityScale:3,repelForce:2,scale:1.2})}var i=document.getElementsByClassName("mermaid");i.length>0&&import("https://unpkg.com/mermaid@9/dist/mermaid.esm.min.mjs").then(e=>{e.default.init()})},init=(e=document)=>{addCopyButtons(),addTitleToCodeBlocks(),renderMathInElement(e.body,{delimiters:[{left:"$$",right:"$$",display:!0},{left:"$",right:"$",display:!1}],macros:{'’':"'"},throwOnError:!1})}</script><script type=module>
    import { attachSPARouting } from "https:\/\/htlin222.github.io\/garden\/js\/router.9d4974281069e9ebb189f642ae1e3ca2.min.js"
    attachSPARouting(init, render)
  </script></head><body><div id=search-container><div id=search-space><input autocomplete=off id=search-bar name=search type=text aria-label=Search placeholder="Search for something..."><div id=results-container></div></div></div><script src=https://cdn.jsdelivr.net/npm/flexsearch@0.7.21/dist/flexsearch.bundle.js integrity="sha256-i3A0NZGkhsKjVMzFxv3ksk0DZh3aXqu0l49Bbh0MdjE=" crossorigin=anonymous defer></script>
<script defer src=https://htlin222.github.io/garden/js/full-text-search.e6e2e0c213187ca0c703d6e2c7a77fcd.min.js></script><div class=singlePage><header><h1 id=page-title><a href=https://htlin222.github.io/garden/>🦎的知識花園</a></h1><div class=spacer></div><div id=search-icon><p>Search</p><svg tabindex="0" aria-labelledby="title desc" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 19.9 19.7"><title id="title">Search Icon</title><desc id="desc">Icon to open search</desc><g class="search-path" fill="none"><path stroke-linecap="square" d="M18.5 18.3l-5.4-5.4"/><circle cx="8" cy="8" r="7"/></g></svg></div><div class=darkmode><input class=toggle id=darkmode-toggle type=checkbox tabindex=-1>
<label id=toggle-label-light for=darkmode-toggle tabindex=-1><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" id="dayIcon" viewBox="0 0 35 35" style="enable-background:new 0 0 35 35"><title>Light Mode</title><path d="M6 17.5C6 16.672 5.328 16 4.5 16h-3C.672 16 0 16.672.0 17.5S.672 19 1.5 19h3C5.328 19 6 18.328 6 17.5zM7.5 26c-.414.0-.789.168-1.061.439l-2 2C4.168 28.711 4 29.086 4 29.5 4 30.328 4.671 31 5.5 31c.414.0.789-.168 1.06-.44l2-2C8.832 28.289 9 27.914 9 27.5 9 26.672 8.329 26 7.5 26zm10-20C18.329 6 19 5.328 19 4.5v-3C19 .672 18.329.0 17.5.0S16 .672 16 1.5v3C16 5.328 16.671 6 17.5 6zm10 3c.414.0.789-.168 1.06-.439l2-2C30.832 6.289 31 5.914 31 5.5 31 4.672 30.329 4 29.5 4c-.414.0-.789.168-1.061.44l-2 2C26.168 6.711 26 7.086 26 7.5 26 8.328 26.671 9 27.5 9zM6.439 8.561C6.711 8.832 7.086 9 7.5 9 8.328 9 9 8.328 9 7.5c0-.414-.168-.789-.439-1.061l-2-2C6.289 4.168 5.914 4 5.5 4 4.672 4 4 4.672 4 5.5c0 .414.168.789.439 1.06l2 2.001zM33.5 16h-3c-.828.0-1.5.672-1.5 1.5s.672 1.5 1.5 1.5h3c.828.0 1.5-.672 1.5-1.5S34.328 16 33.5 16zM28.561 26.439C28.289 26.168 27.914 26 27.5 26c-.828.0-1.5.672-1.5 1.5.0.414.168.789.439 1.06l2 2C28.711 30.832 29.086 31 29.5 31c.828.0 1.5-.672 1.5-1.5.0-.414-.168-.789-.439-1.061l-2-2zM17.5 29c-.829.0-1.5.672-1.5 1.5v3c0 .828.671 1.5 1.5 1.5s1.5-.672 1.5-1.5v-3C19 29.672 18.329 29 17.5 29zm0-22C11.71 7 7 11.71 7 17.5S11.71 28 17.5 28 28 23.29 28 17.5 23.29 7 17.5 7zm0 18c-4.136.0-7.5-3.364-7.5-7.5s3.364-7.5 7.5-7.5 7.5 3.364 7.5 7.5S21.636 25 17.5 25z"/></svg></label><label id=toggle-label-dark for=darkmode-toggle tabindex=-1><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" id="nightIcon" viewBox="0 0 100 100" style="enable-background='new 0 0 100 100'"><title>Dark Mode</title><path d="M96.76 66.458c-.853-.852-2.15-1.064-3.23-.534-6.063 2.991-12.858 4.571-19.655 4.571C62.022 70.495 50.88 65.88 42.5 57.5 29.043 44.043 25.658 23.536 34.076 6.47c.532-1.08.318-2.379-.534-3.23-.851-.852-2.15-1.064-3.23-.534-4.918 2.427-9.375 5.619-13.246 9.491-9.447 9.447-14.65 22.008-14.65 35.369.0 13.36 5.203 25.921 14.65 35.368s22.008 14.65 35.368 14.65c13.361.0 25.921-5.203 35.369-14.65 3.872-3.871 7.064-8.328 9.491-13.246C97.826 68.608 97.611 67.309 96.76 66.458z"/></svg></label></div></header><article><h1>coronary angiography PCI</h1><p class=meta>Last updated
Jan 9, 2023
<a href=https://github.com/htlin222/garden/tree/hugo/content/coronary%20angiography%20PCI.md rel=noopener>Edit Source</a></p><ul class=tags></ul><aside class=mainTOC><details><summary>Table of Contents</summary><nav id=TableOfContents><ol><li><a href=#precath-checklist>Precath checklist</a></li><li><a href=#vascular-access>Vascular access</a></li><li><a href=#periprocedural-pharmacotherapy-for-pci>Periprocedural pharmacotherapy for PCI</a></li><li><a href=#pci-and-peri-pci-interventions>PCI and peri-PCI interventions</a></li><li><a href=#peri-pci-complications>Peri-PCI complications</a></li><li><a href=#vascular-access-post-pci-complications>Vascular access post-PCI complications</a></li><li><a href=#other-complications-nejm-20173771513>Other complications (NEJM 2017;377:1513)</a></li><li><a href=#stent-post-pci-complications>Stent post-PCI complications</a></li><li><a href=#duration-of-dual-antiplatelet-therapy-jacc-2016681082--ehj-201839213>Duration of dual antiplatelet therapy (JACC 2016;68:1082 & EHJ 2018;39:213)</a></li></ol></nav></details></aside><a href=#coronary-angiography-pci><h1 id=coronary-angiography-pci><span class=hanchor arialabel=Anchor># </span>coronary angiography PCI</h1></a><a href=#precath-checklist><h2 id=precath-checklist><span class=hanchor arialabel=Anchor># </span>Precath checklist</h2></a><ul><li>Peripheral arterial exam (radial, femoral, DP, PT pulses; bruits); palmar arch eval (eg, w/ pulse oximetry & plethysmography) not routinely done. ✓ can lie flat × hrs, NPO >6 h.</li><li>✓ CBC, PT-INR (ideally ≤2), Cr; hold ACEI/ARB if renal dysfxn. Blood bank sample.</li><li>↓ risk of contrast-induced kidney injury: hold ACEI/ARB/ARNI, NSAIDs, diuretics. PreRx w/ isotonic IVF: data mixed, but may be helpful if high risk (Lancet 2017;389:1312).</li><li>If iodinated contrast allergy, preRx w/ steroids & antihistamines</li></ul><a href=#vascular-access><h2 id=vascular-access><span class=hanchor arialabel=Anchor># </span>Vascular access</h2></a><ul><li>Radial access preferred for coronary angiography: ↓ major bleeding & vascular complications, and possibly mortality benefit (Circ CI 2018;11:e000035)</li><li>Femoral artery commonly used; high puncture ↑ risk of retroperitoneal bleed; low puncture ↑ risk of arterial complic. (eg, AV fistula, superficial femoral artery cannulation)</li></ul><a href=#periprocedural-pharmacotherapy-for-pci><h2 id=periprocedural-pharmacotherapy-for-pci><span class=hanchor arialabel=Anchor># </span>Periprocedural pharmacotherapy for PCI</h2></a><ul><li>ASA 325 mg × 1. P2Y12 inhibitor: ticagrelor or prasugrel preferred over clopidogrel in ACS. Outside of STEMI, preRx load not recommended when anatomy unknown. Cangrelor (IV P2Y12 inhib) ↓ peri-PCI events vs. clopi w/o PreRx (NEJM 2013;368:1303).</li><li>GP IIb/IIIa inhibitor: sometimes added if periprocedural thrombotic complication</li><li>Anticoagulant: UFH or bivalirudin (if HIT) typically given during case and stopped at end</li></ul><a href=#pci-and-peri-pci-interventions><h2 id=pci-and-peri-pci-interventions><span class=hanchor arialabel=Anchor># </span>PCI and peri-PCI interventions</h2></a><ul><li>Physiology: fractional flow reserve (FFR): ratio of max flow (induced by adenosine) distal vs. prox to stenosis to ID hemodyn. signif. lesions (≤0.80). Instantaneous wave-free ratio (iFR) similar, doesn’t require vasodilator; iFR threshold ≤0.89 (NEJM 2017;376:1813 & 1824).</li><li>Advanced imaging: intravascular U/S (IVUS) or optical coherence tomography (OCT)</li><li>Drug-eluting stents (DES): ↓ cardiac death, MI, repeat revasc, & stent thrombosis vs. BMS (Lancet 2019;393:2503). Balloon angioplasty alone reserved for lesions too narrow to stent.</li></ul><a href=#peri-pci-complications><h2 id=peri-pci-complications><span class=hanchor arialabel=Anchor># </span>Peri-PCI complications</h2></a><ul><li>No or slow reflow: Rx with local delivery of vasodilators</li><li>Coronary artery dissection: treat with stent</li><li>Coronary perforation: immediate balloon tamponade, ✓ for effusion, seal w/ covered stent</li></ul><a href=#vascular-access-post-pci-complications><h2 id=vascular-access-post-pci-complications><span class=hanchor arialabel=Anchor># </span>Vascular access post-PCI complications</h2></a><ul><li>Postprocedure ✓ vascular access site, distal pulses, ECG, CBC, Cr</li><li>Bleeding: reverse/stop anticoag (d/w interventionalist); IV fluids/PRBC/plts as required<ul><li>hematoma/overt bleeding: manual compression</li><li>retroperitoneal bleed: may p/w ↓ Hct ± flank or back pain. CT abd/pelvis (I–) or angio if unstable. If does not auto-tamponade, intravascular balloon and/or covered stent.</li></ul></li><li>Vascular damage (~1% of dx angio, ~5% of PCI; Circ 2007;115:2666)<ul><li><p>pseudoaneurysm: triad of pain, expansile mass, systolic bruit; diagnose w/ U/S;</p><ul><li>Rx (if pain or >2 cm): U/S-directed thrombin injection, surgical repair if former fails</li></ul></li><li><p>AV fistula: continuous bruit; Dx: U/S; Rx: surgical repair if large or sx</p></li></ul></li><li>limb ischemia (emboli, dissection, clot): cool, mottled extremity, ↓ distal pulses; Dx: loss of pulses, ↓ pulse volume recording, angio; Rx: percutaneous or surgical repair</li><li>radial artery occlusion: if sx, consider 4 weeks LMWH</li></ul><a href=#other-complications-nejm-20173771513><h2 id=other-complications-nejm-20173771513><span class=hanchor arialabel=Anchor># </span>Other complications (NEJM 2017;377:1513)</h2></a><ul><li>Contrast-induced AKI: w/in 48 h, peak 3–5 d; pre-hydration reasonable (see “CIAKI”)</li><li>Stroke: ~0.1–0.4% of cases. Usually ischemic from atheroembolic event during cath. Rx depends on sx/location/timing but includes thrombectomy, tPA, DAPT if ischemic.</li><li>Cholesterol emboli syndrome: typically in Pts w/ large burden Ao atheroma; mesenteric ischemia (abd pain, LGIB, pancreatitis); intact distal pulses but livedo and toe necrosis</li></ul><a href=#stent-post-pci-complications><h2 id=stent-post-pci-complications><span class=hanchor arialabel=Anchor># </span>Stent post-PCI complications</h2></a><ul><li>Stent thrombosis: acute clot formation in stent usually in 1st mo but can occur anytime. Typically p/w AMI. Often due to premature d/c antiplt Rx or mech prob. (stent underexpansion or unrecognized dissection, typically presents early).</li><li>In-stent restenosis: develops in previously stented segment mos after PCI. Typically p/w gradual ↑ angina. Due to elastic recoil and neointimal hyperplasia; ↓ w/ DES.</li></ul><a href=#duration-of-dual-antiplatelet-therapy-jacc-2016681082--ehj-201839213><h2 id=duration-of-dual-antiplatelet-therapy-jacc-2016681082--ehj-201839213><span class=hanchor arialabel=Anchor># </span>Duration of dual antiplatelet therapy (JACC 2016;68:1082 & EHJ 2018;39:213)</h2></a><ul><li>DAPT duration determined by patient presentation (ACS vs. SIHD), long-term ischemic risk (patient and procedural risk factors), and bleeding risk</li><li>Antiplt Rx: DAPT (ASA 81 + P2Y12 inhib) in SIHD for 4 wk (BMS) or ≥6 mo (DES); in ACS (qv) for 12 mo and possibly beyond (JAMA Cards 2016;1:627). Data emerging for DAPT 1–3 mo, followed by P2Y12 inhib monotherapy (Circ 2020;142:538).</li><li>If need long-term oral anticoag, consider clopi+DOAC and consider stopping ASA (? after ~1 wk) as ↓ bleed, but trend small ↑ ischemic risk (JAMA Cardiol. 2020;5:582)</li></ul></article><hr><div class=page-end id=footer><div class=backlinks-container><h3>Backlinks</h3><ul class=backlinks><li><a href=/garden/cardiology/ data-ctx="coronary angiography PCI" data-src=/cardiology class=internal-link>cardiology</a></li></ul></div><div><script async src=https://cdn.jsdelivr.net/npm/d3@6.7.0/dist/d3.min.js integrity="sha256-+7jaYCp29O1JusNWHaYtgUn6EhuP0VaFuswhNV06MyI=" crossorigin=anonymous></script><h3>Interactive Graph</h3><div id=graph-container></div><style>:root{--g-node:var(--secondary);--g-node-active:var(--primary);--g-node-inactive:var(--visited);--g-link:var(--outlinegray);--g-link-active:#5a7282}</style><script src=https://htlin222.github.io/garden/js/graph.2d9e48dbe7ea47c0ef1c58296ce14448.js></script></div></div><div id=contact_buttons><footer><p>Made by Hsieh-Ting Lin using <a href=https://github.com/jackyzha0/quartz>Quartz</a>, © 2023</p><ul><li><a href=https://htlin222.github.io/garden/>Home</a></li><li><a href=https://twitter.com/htlin222>Twitter</a></li><li><a href=https://github.com/htlin222>GitHub</a></li></ul></footer></div></div></body></html>